This inventor holds 1 USPTO granted patent. Top assignee: Neurocal International Inc.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Lori Kathleen Klaidman: Innovator in Neural Trauma Treatment
Introduction
Lori Kathleen Klaidman is a prominent inventor based in Santa Monica, CA. She has made significant contributions to the field of neuroscience, particularly in the treatment of neural trauma. Her innovative approach focuses on the use of NAD-related compounds to mitigate neural degeneration.
Latest Patents
Lori holds a patent for the "Use of NAD-related compounds in the treatment of neural trauma." This invention is directed towards methods for reducing the degree of neural degeneration in mammals due to acute neural trauma. The administration of NAD-related compounds, such as nicotinamide adenine dinucleotide (NAD) and its various forms, plays a crucial role in this method.
Career Highlights
Lori is associated with Neurocal International Inc., where she applies her expertise in neuroscience to develop groundbreaking treatments. Her work has the potential to change the landscape of neural trauma recovery.
Collaborations
Lori has collaborated with notable professionals in her field, including James David Adams and Suman Kumar Mukherjee. These partnerships enhance her research and contribute to the advancement of innovative treatments.
Conclusion
Lori Kathleen Klaidman is a trailblazer in the field of neural trauma treatment, with her patent showcasing the potential of NAD-related compounds. Her work at Neurocal International Inc. and collaborations with esteemed colleagues further solidify her impact in the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile